Elevance Health (ELV) Income towards Parent Company (2009 - 2026)

Elevance Health (ELV) has 17 years of Income towards Parent Company data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly Income towards Parent Company fell 19.41% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 billion (down 11.33% YoY) and the FY2025 annual result came in at $5.7 billion, down 5.19% from the prior year.
• Income towards Parent Company grew to $1.8 billion in Q1 2026 per ELV's latest filing, from $546.0 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $2.3 billion in Q2 2024 and bottomed at $413.0 million in Q4 2024.
• The 5-year median for Income towards Parent Company is $1.6 billion (2022), against an average of $1.5 billion.
• The widest annual swing landed in 2024, when Income towards Parent Company slumped 50.3%; it then soared 32.2% in 2025.
• Tracing ELV's Income towards Parent Company over 5 years: stood at $877.0 million in 2022, then declined by 5.25% to $831.0 million in 2023, then tumbled by 50.3% to $413.0 million in 2024, then soared by 32.2% to $546.0 million in 2025, then soared by 222.34% to $1.8 billion in 2026.
• Per Business Quant, the three latest ELV Income towards Parent Company figures stand at $1.8 billion (Q1 2026), $546.0 million (Q4 2025), and $1.2 billion (Q3 2025).

Peer Comparison